AN2 Therapeutics Inc. (ANTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AN2 Therapeutics Inc.

    NASDAQ: ANTX · Real-Time Price · USD
    1.31
    0.03 (2.34%)
    At close: Oct 03, 2025, 3:56 PM
    1.30
    -0.76%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    AN2 Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.8 -7.47 -3.57 -13.4
    PEG Ratio
    		 0.02 4.17 -0.04 -0.15
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 0.50 3.88 1.53 4.66
    P/FCF Ratio
    		 -0.84 -9.07 -4.37 -14.09
    P/OCF Ratio
    		 -0.84 -9.07 -4.37 -14.09
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a n/a 0.00 n/a
    Quick Ratio
    		 8.43 7.87 13.72 17.70
    Current Ratio
    		 8.43 7.87 13.72 17.70
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -82.22 n/a
    Return on Equity
    		 -0.63 -0.52 -0.43 -0.35
    Return on Assets
    		 -0.56 -0.47 -0.4 -0.33
    Return on Invested Capital
    		 -0.67 -0.56 -0.44 -0.35
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist